-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602.P1.59 602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Lara Rizzotto, PhD1, Tzung-Huei Lai, PhD2, Chaomei Liu, BS3*, Arianna Bottoni, PhD1*, Clara D. Bloomfield, MD4, John C Byrd, MD5 and Deepa Sampath, PhD6

1Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2The Ohio State University, Columbus, OH
3MD Anderson Cancer Center, The University of Texas, Houston, TX
4Comprehensive Cancer Center, The Ohio State University, Columbus, OH
5Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH
6Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Yutaka Shima, PhD*, Minori Yumoto* and Issay Kitabayashi, PhD

Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan

Peng Zhang, PhD1*, Shohei Yamamoto, MD, PhD2*, Shi Chen, MD, PhD1*, Yuan Zhou, PhD3*, Mingjiang Xu, MD, PhD1 and Feng-Chun Yang, MD, PhD1

1Department of Biochemistry and Molecular Biology & Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL
2Showa University Fujigaoka Hospital, Yokohama, Japan
3State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Center for Stem Cell Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Yue Zhao, Ph.D.1*, Phillip Liu, Ph.D.2*, Peggy Scherle, Ph.D.2*, Reid Huber, Ph.D.2*, Michael R. Savona, M.D.3* and Scott Hiebert, Ph.D.1

1Department of Biochemistry, Vanderbilt University, Nashville, TN
2Incyte Corporation, Wilmington, DE
3Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Alok Kothari, M.D.1*, Hamza Celik, PhD2, Andrew Martens1*, Cates Mallaney1*, Elizabeth L Ostrander1*, Elizabeth Eultgen1* and Grant A. Challen, PhD2

1Washington University School of Medicine, Saint Louis, MO
2Washington University School of Medicine, St Louis, MO

Frida Linnea Holm, PhD1*, Eva Hellqvist, PhD, MSc2*, Cayla N Mason, BS3*, Shawn Ali, BA1*, Nathaniel Delos Santos3*, Christian Barrett4*, Hye-Jung Chun5*, Mark D. Minden, MD, PhD6, Moore Richard5*, Marco A Marra, PhD7, Kelly A. Frazer8*, Anil Sadarangani, PhD1* and Catriona Jamieson, MD, PhD3

1Division of Regenerative Medicine, University of California San Diego, La Jolla, CA
2Karolinska Institutet, Stockholm, Sweden
3Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA
4Institute of Genomic Medicine, Department of Pediatrics, University of California San Diego, La Jolla
5Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, British Columbia, Vancouver, Canada
6Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
8Institute of Genomic Medicine, Department of Pediatrics, University of California San Diego, La Jolla, CA

Wenhuo Hu, PhD1 and Christopher Y. Park, M.D., Ph.D.2

1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
2Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY

Chen Tian1*, Guoguang Zheng, Phd2*, M. James You, MD, PhD3 and Yizhuo Zhang4*

1Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
2Institute of Hematology, Beijing Union Medical College, Tianjin, China
3Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX
4Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Makoto Yamagishi, Ph.D.1*, Harutaka Katano, D.D.S., Ph.D.2*, Tsunekazu Hishima, M.D., Ph.D.3*, Yasunori Ota, MD, PhD4*, Seiji Okada, M.D., Ph.D.5 and Toshiki Watanabe, M.D., Ph.D.1*

1Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
2Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
3Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
4Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
5Center for AIDS Research, Kumamoto University, Kumamoto, Japan

Xueqin Sun, Ph.D.*, Bin Lu, Ph.D.* and Zan Huang

College of Life Sciences, Wuhan University, Wuhan, China

Arianna Bottoni1*, Rizzotto Lara, PhD2*, Lai Tzung-Huei, PhD2*, Rose Mantel3*, Lisa Simith2*, Dalia El-Gamal, PhD3, Amy J. Johnson, PhD3, Rosa Lapalombella, PhD3, James S. Blachly, MD3, John C. Byrd, MD3, Jennifer A. Woyach, MD3 and Deepa Sampath, PhD4

1Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2The Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Heesue PARK1*, Heewon Seo2*, Si Nae Park3*, Kyoungok Im3*, Jung Ah Kim1*, Sang Mee Hwang4*, Ju Han Kim2* and Dong Soon Lee1

1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
2Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, South Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
4Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea

Fuling Zhou, PhD, MD

1Department of Clinical Hematology, Xi’an Jiaotong University, xi'an, China; The University of Texas MD Anderson Cancer Center, Houston, TX

Joo Hyun Lee, BS1*, Cynthia R. Giver, PhD2, Sravanti Rangaraju, MD, MBBS3* and Edmund K Waller, MD, PhD2

1Emory University, Atlanta, GA
2Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
3Department of Medicine, University of Minnesota, Minneapolis, MN

Margaret M. Pruitt, PhD*, Sean C. McConnell, PhD, BS, Anthony Restaino, BS*, Wilfredo Marin, MS* and Jill L. O. de Jong, MD, PhD

Department of Pediatrics, University of Chicago, Chicago, IL

Natanja Oosterom1,2*, Ángela Guttiérez-Camino3*, Marissa Den Hoed1,4*, Elixabet López-López3*, Saskia MF Pluijm1,4*, Rob Pieters, MD, PhD5, Robert de Jonge2*, Wim JE Tissing, MD, PhD6*, África García-Orad3*, Sandra G Heil2* and Marry M van den Heuvel-Eibrink1,4

1Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands
2Department of Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands
3Department of Genetics, Physical Anthropology and Animal physiology, Faculty of Medicine and Odontology, University of the Basque Country (UPV/EHU), Leioa, Spain
4Department of Paediatric Oncology/Hematology, Erasmus MC-Sophia’s Children’s Hospital, Rotterdam, Netherlands
5Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
6Department of Paediatric Oncology, University Medical Center Groningen, Groningen, Netherlands

Limengmeng Wang1*, Haowen Xiao1,2*, Xing Zhang1,3*, Weichao Liao1*, Shan Fu1* and He Huang, MD, PhD1

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University, School of Medicine., Hangzhou, China
2Department of Haematology, Guangzhou Liuhuaqiao Hospital, Guangzhou, China
3Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine., Hangzhou, China

Ayako Arai, MD, PhD1, Hiroshi Takase, MD, PhD2*, Kouhei Yamamoto, MD, PhD3*, Hiroki Akiyama, MD1*, Manabu Mochizuki, MD, PhD2* and Osamu Miura, MD, PhD1

1Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
2Department of Ophthalmology, Tokyo Medical and Dental University, Bunkyo-ku, Japan
3Department of Comprehensive Pathology, Tokyo Medical and Dental University, Bunkyo-ku, Japan

*signifies non-member of ASH